Cargando…
Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
BACKGROUND: Metastatic burden and aggressive behavior determine severity stratification and guide treatment decisions in prostate cancer (PCa). Monoamine oxidase A (MAOA) may promote tumor burden and drug/castration resistance in PCa. A positive association will pave the way for MAOA inhibitors such...
Autores principales: | Meenu, Meenakshi, Verma, Vipin Kumar, Seth, Amlesh, Sahoo, Ranjit Kumar, Gupta, Pooja, Arya, Dharamvir Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674122/ https://www.ncbi.nlm.nih.gov/pubmed/33245296 http://dx.doi.org/10.1016/j.curtheres.2020.100610 |
Ejemplares similares
-
Efficacy and safety of (225)Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
por: Yadav, Madhav Prasad, et al.
Publicado: (2020) -
Long-term outcome of (177)Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients
por: Yadav, Madhav Prasad, et al.
Publicado: (2021) -
Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection
por: Bahl, Amul S., et al.
Publicado: (2022) -
Monoamine oxidase A: An emerging therapeutic target in prostate cancer
por: Chen, Chia-Hui, et al.
Publicado: (2023) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)